From Cheerios box trade dress to generic “googling” to a blockbuster U.S. Supreme Court decision, 2017 was another bumper year for major rulings in trademark law. Here are the 10 you need to remember.
International pharmaceutical companies are ramping up their investments in India in anticipation of the introduction of product patents in the country in 2005, according to local reports.
California-based O2Micro International Ltd. has sued Korean electronics maker Samsung Electronics Co. Ltd. over patents for liquid crystal display (LCD) monitors.
A federal judge has dismissed part of a trademark infringement lawsuit brought by Nasdaq Stock Market Inc. against Archipelago Holdings Inc. over Archipelago's trading of a highly liquid type of securities that Nasdaq claims as its intellectual property.
A federal judge in California has granted summary judgment for Akami, Inktomi, Yahoo, Microsoft, and Netscape in Teknowledge's patent lawsuit over of a web caching technology.
The chairman of the Senate Judiciary Committee has written a letter to Senate appropriators, urging them to increase funding for the U.S. Patent and Trademark Office to avert delays of up to four years for patent applications.
Denver partner Lee Osman has been tapped to head the international law firm Dorsey & Whitney’s intellectual property practice, the firm said.
A federal court in Delaware has overturned a $7.1 million jury verdict for patent infringement against several of the nation's largest umbilical-cord blood banks and granted the defendants a new trial.
Pfizer Inc. has quietly been lobbying China's State Intellectual Property Office to restore the company's domestic-use patent for the erectile-dysfunction drug Viagra, according to a published report.
Luxury pen maker Montblanc North America LLC has sued rival A.T. Cross Co. for alleged trademark infringement and false advertising.
Senate appropriators have approved a funding bill that would raise fees for the U.S. Patent and Trademark Office and ban the diversion of funds collected by the USPTO to other federal programs for the next year.
Synopsys and Magma Design Automation, two California rivals in the semiconductor field of electronic design automation, are facing off in a dispute over patent rights and trade secrets.
U.K-Swedish drug maker AstraZeneca has sued generic maker KV Pharmaceutical Company for patent infringement over its plans to launch a 50 mg generic version of hypertension drug Toprol-XL.
The U.S. is “seriously considering” reinstating Israel on its blacklist of intellectual property violators as a result of the Israeli cabinet’s approval of a bill that falls short of U.S. and European demands for better patent protection for pharmaceuticals, according to local news reports.
Fish & Neave, one of the oldest and most prominent intellectual property firms in the U.S., has held preliminary talks with Boston-based Ropes & Gray about a possible merger, according to a report.
A case involving the Vatican, ancient art works and a forged 45-year-old license agreement recently took Hogan & Hartson LLP’s intellectual property litigators into legal territory no law school could have prepared them for.
Infosys, one of India’s top information technology companies, is going to the country’s Supreme Court to fight off a challenge to the company’s well-known trademark.
Eight attorneys have joined Baker & Daniels’s intellectual property practice in the firm’s Indianapolis downtown office from local rival Bose McKinney & Evans LLC.
Minority-owned national law firm Adorno & Yoss has gained a foothold in New York through its acquisition of the seven-lawyer Bryant Law Group, whose practice focuses on corporate law and intellectual property.
The U.S. Court of Appeals for the Federal Circuit’s landmark Knorr-Bremse ruling won’t hurt opinion practices at boutique firms, the president of the Association of Patent Law Firms insisted.
The U.S. Court of Appeals for the Federal Circuit has ruled that Scientific-Atlanta infringed on a patent held by Gemstar-TV Guide International, overturning a decision by the ITC.